Vericel (VCEL) Depreciation and Depletion (2014 - 2026)
Vericel (VCEL) reported Depreciation and Depletion of $3.1 million for Q1 2026, up 24.0% on a YoY basis from $2.5 million in Q1 2025, and up 6.9% sequentially from $2.9 million in Q4 2025.
Vericel (VCEL) Depreciation and Depletion (2014 - 2026) Analysis & Trends
Vericel (VCEL) has 10 years of Depreciation and Depletion data on file, last reported at $3.1 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion rose 24.0% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $11.5 million (up 82.54% YoY), and the FY2025 full-year result was $10.9 million, up 122.45% from the prior year.
- Depreciation and Depletion climbed to $3.1 million in Q1 2026, from $2.9 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $3.1 million in Q1 2026 to a low of $900000.0 in Q1 2022.
- A 5-year average of $1.6 million and a median of $1.2 million in 2024 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion decreased 9.09% in 2023 and soared 133.33% in 2025, its largest moves.
- Tracing VCEL's Depreciation and Depletion over 5 years: stood at $1.1 million in 2022, then retreated by 9.09% to $1.0 million in 2023, then jumped by 40.0% to $1.4 million in 2024, then jumped by 107.14% to $2.9 million in 2025, then increased by 6.9% to $3.1 million in 2026.
- Business Quant data shows VCEL's Depreciation and Depletion at $3.1 million in Q1 2026, $2.9 million in Q4 2025, and $2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 3.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.10 Mn |
| Mar 31, 2026 | 3.10 Mn |
| Dec 31, 2025 | 2.90 Mn |
| Dec 31, 2025 | 2.90 Mn |
| Sep 30, 2025 | 2.80 Mn |
| Sep 30, 2025 | 2.80 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |